ABSTRACT
Sequence variability in the S1 gene determines the genotype of infectious bronchitis virus (IBV) strains. A single RT-PCR assay was developed to amplify and sequence the full S1 gene for six classical and variant IBVs (M41, D274, 793B, IS/885/00, IS/1494/06 and Q1) enriched in allantoic fluid (AF) or the same AF inoculated onto Flinders Technology Association (FTA) cards. Representative strains from each genotype were grown in specific-pathogen-free eggs and RNA was extracted from AF. Full S1 gene amplification was achieved using primer A and primer 22.51. Products were sequenced using primers A, 1050+, 1380+ and SX3+ to obtain short sequences covering the full gene. Following serial dilutions of AF, detection limits of the partial assay were higher than those of the full S1 gene. Partial S1 sequences exhibited higher-than-average nucleotide similarity percentages (79%; 352â bp) compared to full S1 sequences (77%; 1756â bp), suggesting that full S1 analysis allows greater strain differentiation. For IBV detection from AF-inoculated FTA cards, four serotypes were incubated for up to 21 days at three temperatures, 4°C, room temperature (approximately 24°C) and 40°C. RNA was extracted and tested with partial and full S1 protocols. Through partial sequencing, all IBVs were successfully detected at all sampling points and storage temperatures. In contrast, using full S1 sequencing it was not possible to amplify the gene beyond 14 days or when stored at 40°C. Data presented show that for full S1 sequencing, a substantial amount of RNA is needed. Field samples collected onto FTA cards are unlikely to yield such quantity or quality. ABBREVIATIONS: AF: allantoic fluid; CD50: ciliostatic dose 50; FTA: Flinders Technology Association; IB: infectious bronchitis; IBV: infectious bronchitis virus.
Subject(s)
Chickens/virology , Coronavirus Infections/veterinary , Infectious bronchitis virus/genetics , Poultry Diseases/virology , Spike Glycoprotein, Coronavirus/genetics , Allantois/virology , Animals , Coronavirus Infections/diagnosis , Coronavirus Infections/virology , Extracellular Fluid/virology , Female , Genotype , Ovum/virology , Phylogeny , Poultry Diseases/diagnosis , Sensitivity and Specificity , Sequence Analysis, DNA/veterinary , Specific Pathogen-Free Organisms , Specimen Handling/veterinary , TemperatureABSTRACT
The HCV NS5A protein is essential for viral RNA replication and virus particle assembly. To study the viral replication cycle and NS5A biology we generated an infectious HCV construct with a NanoLuciferase (NLuc) insertion within NS5A. Surprisingly, beyond its utility as a sensitive reporter of cytoplasmic viral RNA replication, we also observed strong luminescence in cell culture fluids. Further analysis using assembly-defective viruses and subgenomic replicons revealed that infectious virus production was not required for extracellular NS5A-NLuc activity but was associated with enrichment of extracellular NS5A-NLuc in intermediate-density fractions similar to those of exosomes and virus particles. Additionally, BRET analysis indicated that intracellular and extracellular forms of NS5A may adopt differing conformations. Importantly, infection studies using a human liver chimeric mouse model confirmed robust infection in vivo and ready detection of NLuc activity in serum. We hypothesise that the presence of NS5A in extracellular fluids contributes to HCV pathogenesis.
Subject(s)
Extracellular Fluid/virology , Hepacivirus/metabolism , Hepatitis C/virology , Luciferases/metabolism , Viral Nonstructural Proteins/metabolism , Animals , Genes, Reporter , Hepacivirus/genetics , Humans , Luciferases/genetics , Mice , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Viral Nonstructural Proteins/geneticsSubject(s)
Cervix Uteri/virology , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/transmission , Extracellular Fluid/virology , Infectious Disease Transmission, Vertical , Muromegalovirus/genetics , Polymerase Chain Reaction , Cytomegalovirus Infections/virology , DNA, Viral , Female , Humans , Polymerase Chain Reaction/methods , Prenatal Diagnosis , PrognosisABSTRACT
The formation of chemical cross-links between nucleic acids and proteins in formalin-containing media presents challenges for human papillomavirus (HPV) testing of cervical samples collected in SurePath Preservative Fluid. A preanalytic process involving addition of a nucleophilic buffer and heating the sample to 120°C was developed to reverse the effects of cross-linking and improve nucleic acid accessibility for the cobas HPV Test in SurePath. Cycle threshold (CT) values for cobas HPV detection were evaluated over time and various temperatures, and mean CT differences between pretreated and both untreated SurePath samples and those collected in PreservCyt were assessed. Without pretreatment, low viral levels (1 × limit of detection) of HPV were no longer detectable by 7 days. For prospectively collected specimens, mean (95% CI) CT differences between pretreated and untreated samples indicated enhanced HPV DNA recovery in all categories of treated samples: -2.58 (-3.16 to -2.01), -2.63 (-3.62 to -1.64), and -3.39 (-4.95 to -1.82), respectively, for other 12 high-risk HPV types, HPV16, and HPV18. Furthermore, mean (95% CI) CT differences of pretreated SurePath samples were comparable to simultaneously collected PreservCyt samples: -0.48 (-0.98 to 0.02) and -0.23 (-0.93 to 0.46), respectively, for HPV16 and HPV18; a borderline significant difference [-0.35 (-0.57 to -0.13)] was observed for other 12 high-risk HPV types. This preanalytic procedure therefore ensures a validated, safe, and accurate method for cobas HPV testing in SurePath.
Subject(s)
Extracellular Fluid/virology , Papillomaviridae/genetics , Papillomavirus Infections/diagnosis , Papillomavirus Infections/virology , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/standards , Adult , Cervix Uteri/virology , DNA, Viral/genetics , Female , Humans , Middle Aged , Papillomaviridae/classification , Polymerase Chain Reaction/instrumentation , Reproducibility of Results , Sensitivity and Specificity , Specimen Handling/methods , Specimen Handling/standards , Young AdultABSTRACT
The CD200:CD200R1 inhibitory signaling pathway has been implicated in playing a prominent role in limiting inflammation in a wide range of inflammatory diseases. CD200R1 signaling inhibits the expression of proinflammatory molecules including tumor necrosis factor, interferons, and inducible nitric oxide synthase in response to selected stimuli. Unsurprisingly, due to the regulatory role that CD200R1 plays in multiple inflammatory pathways, an increasing number of parasitic, bacterial, and viral pathogens exploit this pathway to suppress host defenses. A complete understanding of the pathways regulated by CD200R1 signaling and the diverse mechanisms that pathogens have evolved to manipulate the CD200:CD200R1 pathway can help identify clinical situations where targeting this interaction can be of therapeutic benefit. In this review, we compare CD200R1 to other pathogen-targeted inhibitory receptors and highlight how this signaling pathway is utilized by a diverse number of pathogens and, therefore, may represent a novel targeting strategy for the treatment of infectious diseases.
Subject(s)
Antigens, CD/physiology , Antigens, Surface/physiology , Host-Pathogen Interactions/immunology , Receptors, Cell Surface/physiology , Signal Transduction/immunology , Animals , Extracellular Fluid/immunology , Extracellular Fluid/microbiology , Extracellular Fluid/virology , Host-Pathogen Interactions/genetics , Humans , Immunoglobulins/physiology , Inflammation/genetics , Inflammation/microbiology , Inflammation/virology , Influenza, Human/genetics , Influenza, Human/immunology , Influenza, Human/virology , Lectins, C-Type/physiology , Mice , Orexin Receptors , Orthomyxoviridae Infections/genetics , Orthomyxoviridae Infections/immunology , Receptors, Cell Surface/deficiency , Receptors, KIR/administration & dosage , Receptors, KIR/genetics , Signal Transduction/geneticsABSTRACT
Innate immune receptors represent an evolutionarily ancient system that allows organisms to detect and rapidly respond to pathogen- and host-derived factors. TLRs are predominantly expressed in immune cells and mediate such a response. Although this class of pattern recognition receptors is involved in CNS disorders, the knowledge of ligands leading to activation of TLRs and to subsequent CNS damage is limited. We report in this study that ssRNA causes neurodegeneration and neuroinflammation dependent on TLR7 in the CNS. TLR7 is not only expressed in microglia, the major immune cells of the brain, but also in neurons of the CNS. Extracellularly delivered ssRNA40, an oligoribonucleotide derived from HIV and an established ligand of TLR7, induces neuronal cell death dependent on TLR7 and the central adapter molecule MyD88 in vitro. Activation of caspase-3 is involved in neuronal damage mediated by TLR7. This cell-autonomous neuronal cell death induced by ssRNA40 is amplified in the presence of microglia that mount an inflammatory response to ssRNA40 through TLR7. Intrathecal administration of ssRNA40 causes widespread neurodegeneration in wild-type but not in TLR7(-/-) mice, confirming that neuronal cell death induced by ssRNA40 through TLR7 occurs in vivo. Our results point to a possible mechanism through which extracellularly delivered ssRNA contributes to CNS damage and determine an obligatory role for TLR7 in this pathway.
Subject(s)
Extracellular Fluid/immunology , Extracellular Fluid/virology , Membrane Glycoproteins/physiology , Neurodegenerative Diseases/immunology , Neurodegenerative Diseases/virology , RNA, Viral/administration & dosage , Toll-Like Receptor 7/physiology , Animals , Caspase 3/adverse effects , Caspase 3/physiology , Cell Death/genetics , Cell Death/immunology , Cell Line, Tumor , HEK293 Cells , HIV/genetics , HIV/immunology , Humans , Injections, Spinal , Membrane Glycoproteins/deficiency , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88/adverse effects , Myeloid Differentiation Factor 88/physiology , Neurodegenerative Diseases/pathology , Primary Cell Culture , RNA, Viral/adverse effects , RNA, Viral/metabolism , Signal Transduction/genetics , Signal Transduction/immunology , Toll-Like Receptor 7/deficiency , Toll-Like Receptor 7/geneticsABSTRACT
The viral protein 22 (VP22) in the tegument of Marek's disease virus serotype 1 (MDV-1) plays an important role in cell-to-cell spread and viral propagation. Antiserum against the carboxyl terminus of VP22 was prepared by immunizing mice with recombinant VP22 expressed in E. coli, and used to investigate its expression in chicken embryo fibroblast (CEF) cells infected with different MDV-1 strains. At an infection dose of PFU=50, intercellular trafficking of the VP22 into the nuclei of the surrounding receipt cells was detected as early as 3 hours post infection. By 6 hours after infection (before viral plague formation), the protein was detected in the whole nuclei of the recipient cells with no difference among MDV-1 strains CVI988/Rispens, GA and RB1B. Intra-nuclear accumulation of the VP22 protein was further increased when the viral plagues started to form. These results indicate that, albeit the existence of the 201TKSERT206 deletion, the VP22 of the CVI988/Rispens vaccine strain has also intercellular-trafficking function, which might serve as a potential alternative delivering protein instead of virulent strains VP22.
Subject(s)
Extracellular Fluid/metabolism , Extracellular Fluid/virology , Mardivirus/physiology , Marek Disease Vaccines/metabolism , Viral Proteins/genetics , Viral Structural Proteins/biosynthesis , Viral Structural Proteins/genetics , Animals , Cells, Cultured , Chick Embryo , Fibroblasts/metabolism , Fibroblasts/virology , Mardivirus/metabolism , Mardivirus/pathogenicity , Protein Transport/physiology , Viral Proteins/biosynthesis , VirulenceABSTRACT
We investigated the feasibility of using Flinders Technology Associates (FTA) filter cards for the storage of allantoic fluid containing an infectious bronchitis virus (IBV), such as Arkansas-DPI, Connecticut, and Massachusetts, and for their identification by reverse transcriptase (RT)-polymerase chain reaction (PCR) and characterization by restriction fragment length polymorphism (RFLP) or nucleotide sequencing. FTA paper is a cotton-based cellulose membrane containing lyophilized chemicals that lyses many types of bacteria and viruses. IBV was inactivated upon contact with the FTA, as shown by the inability of the virus to be propagated in embryonating chicken eggs. RT-PCR of the S1 gene showed that viral RNA in allantoic fluid remained stable after storage on FTA filter cards and that the stability was time and temperature sensitive for the large (1700 base pair [bp]) but not the small (383 bp) PCR products. Analysis of the amplified products showed that molecular characterization is feasible in allantoic fluid stored on FTA under nonfavorable environmental conditions (41 C) for at least 15 days. The use of FTA cards for the collection, transport, and storage of IBV-containing samples is safe, inexpensive, and adequate for molecular diagnosis. We propose that specimens coming from overseas on FTA cards would be first analyzed by RT-PCR with primers yielding a 1700-bp product followed by RFLP of the positive cases. Negative cases would be analyzed with primers yielding a 383-bp product (to exdude detrimental effect of the storage conditions) followed by nucleotide sequencing of the positive cases.
Subject(s)
Chickens/virology , Extracellular Fluid/virology , Infectious bronchitis virus/genetics , Specimen Handling/veterinary , Allantois/chemistry , Animals , Computational Biology , DNA Primers , Filtration/instrumentation , Paper , Polymorphism, Restriction Fragment Length , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Sensitivity and Specificity , Sequence Analysis, DNA/veterinary , Specimen Handling/instrumentation , Temperature , Time Factors , Virus InactivationABSTRACT
Reversible opening of the endothelial barrier remains a major obstacle when hearts are transfected via the coronary system. Our aim was to establish an experimental system permitting the continuous analysis of vascular transfer of virus in the intact heart. Isolated saline-perfused rat hearts were inverted and covered with a latex cap to collect interstitial transudate (IT) on the pericardial surface. Adenovirus (10(9) pfu/ml) was stably labeled with rhodamine fluorescent dye. Analysis of IT and coronary perfusate revealed that under baseline conditions, adenovirus in the IT reached 75% of its vascular concentration within 3 min. The nitric oxide-donors S-nitroso-N-acetyl penicillamine (SNAP) and bradykinin (BK) were the most effective substances to increase total IT volume and adenoviral interstitial concentration. Perfusion with 9% serum markedly reduced IT volume flow and delayed the SNAP/BK effect. Our findings demonstrate that SNAP and BK effectively increased coronary transfer of adenovirus suggesting that the inverted isolated heart is a suitable model to optimize vascular transfer of virus under standardized conditions.
Subject(s)
Adenoviridae/physiology , Coronary Vessels/virology , Myocardium/metabolism , Nitric Oxide/metabolism , Adenoviridae/isolation & purification , Animals , Bradykinin/pharmacology , Extracellular Fluid/virology , Exudates and Transudates/virology , Fluorescent Dyes , In Vitro Techniques , Male , Nitric Oxide Donors/pharmacology , Rats , Rats, Wistar , Rhodamines , S-Nitroso-N-Acetylpenicillamine/pharmacologyABSTRACT
Vaccination of mice with a peptide corresponding to the extracellular part of M2 protein coupled to the immunodominant domain of hepatitis B core can protect mice from a lethal challenge with influenza A virus. As the extracellular part of M2 protein is highly conserved in all known human influenza A strains, such a vaccine may protect against all human influenza A strains, which would represent a major advantage over current vaccine strategies. The present study demonstrates that protection is mediated exclusively by Abs, a very important feature of a successful preventive vaccine. However, these Abs neither bind efficiently to the free virus nor neutralize virus infection, but bind to M2 protein expressed on the surface of virus-infected cells. The presence of NK cells is important for protection, whereas complement is not, supposing that protection is mediated via Ab-dependent, cell-mediated cytotoxicity. The absence of neutralizing Abs results in much weaker protection than that achieved by vaccination with UV-inactivated influenza virus. Specifically, whereas neutralizing Abs completely eliminate signs of disease even at high viral challenge doses, M2-specific Abs cannot prevent infection, but merely reduce disease at low challenge doses. M2-specific Abs fail to protect from high challenge doses, as vaccinated mice undergo lethal infection under these conditions. In conclusion, protection mediated by M2-hepatitis B core vaccine would be insufficient during the yearly epidemics, for which full protection is desirable, and overall is clearly inferior to protection achieved by immunization with classical inactivated viral preparations.